Additionally, Moody’s assigned its “A1” rating to Lucile Packard Children’s Hospital’s proposed $200 million series 2017A revenue bonds, issued by the California Health and Finance Authority. The bonds will mature in 2057.
The downgrade is a result of several factors, including LPCH’s 32 percent increase in debt due to the new bonds, poor operating performance, challenging payer mix, increased spending from an expansion project and temporary reduction of high revenue services. Moody’s also acknowledged the hospital’s healthy balance sheet, strong market position, affiliation with Stanford University and favorable revenue growth.
The outlook is stable, reflecting Moody’s expectation that the hospital will see improved operating performance and balance sheet metrics in fiscal year 2018 to offset the heavy debt load.
More articles on healthcare finance:
Majority of $30M gift from NFL to NIH will go unused
Vermont hospitals seek $86.9M increase in funds from patients, insurers in FY 2018
Lawsuit claims hospitals are improperly using New Mexico’s malpractice fund
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
